Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#4437 Pancreatic metastases in neuroendocrine neoplasia: A systematic review

Introduction: Neuroendocrine neoplasias (NENs) are a heterogeneous group of neoplasms that often metastasise to distant organs, with the liver and bones as common targets. However, metastases to the pancreas are uncommon, accounting for 2–5% of pancreatic malignancies.

Conference:

Presenting Author:

Authors: Rinzivillo M, Romano E, Dell' Unto E, Marasco M, Panzuto F,

Keywords: pancreatic metastasis, 68Gallium-PET, incidence,

#4160 Pancreatic neuroendocrine tumors mimicking pancreatic metastases from renal neoplasms

Introduction: The CT-finding of a hypervascular pancreatic lesion in patients with past nephrectomy for renal clear cell cancer (RCC) or synchronous renal neoplasm is suspected for pancreatic metastasis from RCC.

Conference:

Presenting Author: Milanetto A

Authors: Pasquali C, Armellin C, Milanetto A,

Keywords: renal clear cell cancer, pancretic NET,

#3632 Medullary thyroid carcinoma and somatostatin analogues, a possible therapeutic choice in asymptomatic and slow radiological progression metastatic recurrent disease after surgery – Case report of a 22-years long term survival patient

Introduction: Medullary thyroid carcinoma (MTC) is a well-differentiated neuroendocrine tumor of the thyroid and accounts for 1%-2% of thyroid cancers in the United States. MTCs present with locoregional metastasis in 50% of patients and distant metastasis in 10%-15% at diagnosis. Treatment options for recurrent or progressive disease according to RECIST 1.1 criteria, are limited. Tyrosine kinase-inhibitors (TKI) are preferred as first-line systemic therapy. Although somatostatin analogues (SSA) may play a role in MTC, limited evidence is available.

Conference:

Presenting Author: Raia S

Authors: Raia S, Chiloiro S, Maratta M, Giampietro A, de Marinis L,

Keywords: medullary thyroid carcinoma (MTC), somatostatin analogues, survival,

#717 A Pancreatic Metastasis from Carcinoid Midgut Tumor

Introduction: Metastatic lesions to the pancreas are rare.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Pasquali C

Authors: Moletta L, Milanetto A, Alaggio R, Sperti C, Pedrazzoli S,

Keywords: pancreatic metastasis, midgut carcinoid, pancreatic resection,